BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $93 at Canaccord Genuity

August 6, 2024 8:16 AM EDT
Get Alerts BMRN Hot Sheet
Price: $67.36 -1.71%

Rating Summary:
    25 Buy, 10 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Canaccord Genuity analyst Whitney Ijem raised the price target on BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) to $93.00 (from $89.00) while maintaining a Hold rating.

You May Also Be Interested In





Related Categories

Analyst PT Change